Clinical Trial Update: Efficacy of AC-170 for the Treatment of Allergic Conjunctivitis in the Conjunctival Allergen Challenge (CAC) Model [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial evaluating AC-170 for allergic conjunctivitis using the conjunctival allergen challenge model has completed and results were posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis

Drugs mentioned

• AC-170

Snippet

Sponsor: Aciex Therapeutics, Inc. | Conditions: Allergic Conjunctivitis | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2017-08-30